Argonautic Ventures Investors

"Argonautic Ventures understood the value of Molecular Assemblies and the need for improved DNA synthesis methods. The Argonautic team was an early backer and we value their strategic input and continued partnership as we scale and broaden the synthetic biology market into new areas such as life sciences, agriculture and DNA data storage."


Investors

Number Of Exists: 11
Employee Number: 1-10
Founded Date: 2017-01-01
Headquarters: Grand Cayman, Midland, Cayman Islands
Investment Stage: Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Seed
Industry: Finance, Financial Services, Venture Capital
Investor Type: Fund Of Funds, Hedge Fund, Venture Capital